4.3 Review

Point-of-care testing with high-sensitivity cardiac troponin assays: the challenges and opportunities

Related references

Note: Only part of the references are listed.
Article Medical Laboratory Technology

Determination of sex-specific 99th percentile upper reference limits for a point of care high sensitivity cardiac troponin I assay

Fred S. Apple et al.

Summary: This study determined the sex-specific 99th percentile upper reference limits for hs-cTnI using plasma from the AACC universal sample bank. The results showed significant differences in concentrations between males and females, with the 99th percentile upper reference limits for males at 27 ng/L and females at 18 ng/L.

CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2021)

Article Medical Laboratory Technology

Comparison of the analytical performance of the PATHFAST high sensitivity cardiac troponin I using fresh whole blood vs. fresh plasma samples

Vinajak Gopi et al.

Summary: The study demonstrated excellent correlation and agreement between whole blood and plasma hs-cTnI, with comparable discriminatory ability in distinguishing NSTEMI. Therefore, whole blood can be used interchangeably with plasma for more convenient and less time and labor-consuming testing of hs-cTnI on the PATHFAST instrument.

CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2021)

Article Medical Laboratory Technology

Analytical characterization and clinical performance evaluation of a new point-of-care testing system for high-sensitivity cardiac troponin I assay

Rui Zhang et al.

Summary: The SuperFlex POCT system demonstrated good analytical performance and diagnostic accuracy for acute myocardial infarction, with 100% sensitivity, 81.25% specificity, 57% positive predictive value, and 100% negative predictive value.

ANNALS OF CLINICAL BIOCHEMISTRY (2021)

Article Medical Laboratory Technology

Determination of sex-specific 99th percentile upper reference limits for a point of care high sensitivity cardiac troponin I assay

Fred S. Apple et al.

Summary: This study determined the sex-specific 99th percentile upper reference limits for high sensitivity cardiac troponin assays using heparinized plasma. Results showed significant differences in concentrations between males and females, with the male 99th percentile upper limit higher than females, and varying percentages of subjects with measurable concentrations above the limit of detection.

CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2021)

Article Medical Laboratory Technology

Comparison of the analytical performance of the PATHFAST high sensitivity cardiac troponin I using fresh whole blood vs. fresh plasma samples

Vinajak Gopi et al.

Summary: The study found excellent correlation and agreement between whole blood and plasma hs-cTnI measured with the PATHFAST assay, demonstrating comparable discriminatory ability for diagnosing NSTEMI. This suggests that whole blood can be used interchangeably with plasma for convenient and efficient testing of hs-cTnI.

CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2021)

Article Cardiac & Cardiovascular Systems

RAPID-CPU: a prospective study on implementation of the ESC 0/1-hour algorithm and safety of discharge after rule-out of myocardial infarction

Kiril M. Stoyanov et al.

EUROPEAN HEART JOURNAL-ACUTE CARDIOVASCULAR CARE (2020)

Article Medical Laboratory Technology

Analytical validation of a highly sensitive point-of-care system for cardiac troponin I determination

Federica Braga et al.

CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2020)

Article Emergency Medicine

Point-of-Care Troponin Testing during Ambulance Transport to Detect Acute Myocardial Infarction

Jason P. Stopyra et al.

PREHOSPITAL EMERGENCY CARE (2020)

Article Cardiac & Cardiovascular Systems

Early Diagnosis of Myocardial Infarction With Point-of-Care High-Sensitivity Cardiac Troponin I

Jasper Boeddinghaus et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2020)

Article Medicine, General & Internal

Widespread Introduction of a High-Sensitivity Troponin Assay: Assessing the Impact on Patients and Health Services

Jaimi H. Greenslade et al.

JOURNAL OF CLINICAL MEDICINE (2020)

Article Cardiac & Cardiovascular Systems

Outcome of Applying the ESC O/1-hour Algorithm in Patients With Suspected Myocardial Infarction

Raphael Twerenbold et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2019)

Article Medical Laboratory Technology

Diagnostic Evaluation of a High-Sensitivity Troponin I Point-of-Care Assay

Nils A. Soerensen et al.

CLINICAL CHEMISTRY (2019)

Article Cardiac & Cardiovascular Systems

Cardiac Troponin Elevation in Patients Without a Specific Diagnosis

Kai M. Eggers et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2019)

Article Cardiac & Cardiovascular Systems

Fourth Universal Definition of Myocardial Infarction (2018)

Kristian Thygesen et al.

CIRCULATION (2018)

Article Cardiac & Cardiovascular Systems

Validity of a Novel Point-of-Care Troponin Assay for Single-Test Rule-Out of Acute Myocardial Infarction

John W. Pickering et al.

JAMA CARDIOLOGY (2018)

Review Medicine, General & Internal

Acute Myocardial Infarction

Jeffrey L. Anderson et al.

NEW ENGLAND JOURNAL OF MEDICINE (2017)

Article Cardiac & Cardiovascular Systems

Providing Rapid Out of Hospital Acute Cardiovascular Treatment 4 (PROACT-4)

Justin A. Ezekowitz et al.

JOURNAL OF THE AMERICAN HEART ASSOCIATION (2015)

Review Medical Laboratory Technology

Analytical Characteristics of High-Sensitivity Cardiac Troponin Assays

Fred S. Apple et al.

CLINICAL CHEMISTRY (2012)

Article Cardiac & Cardiovascular Systems

Universal definition of myocardial infarction

Kristian Thygesen et al.

CIRCULATION (2007)

Article Medical Laboratory Technology

Analytical performance of the i-STAT cardiac troponin I assay

FS Apple et al.

CLINICA CHIMICA ACTA (2004)